ProCE Banner Activity

Systemic Mastocytosis: Characteristics and Emerging Therapies

Clinical Thought

Read this expert commentary for a quick overview of the characteristics and causes of systemic mastocytosis and emerging treatment options. 

Released: April 15, 2025

Expiration: April 14, 2026

Share

Provided by

Provided by Partners for Advancing Clinical Education (PACE), in collaboration with the Coalition of Skin Diseases (CSD).

ProCE Banner

Supporters

Supported by an educational grant from Blueprint Medicines.

Blueprint Medicines

Partners

Coalition of Skin Diseases (CSD)

ProCE Banner

Disclosure

Primary Author

Kristine J. Kucera, PA-C, MPAS, DHS: consultant/advisor/speaker: AbbVie, Amgen, Arcutis, Beiersdorf, Bristol Myers Squibb, Ferndale, Galderma, Johnson & Johnson, Leo, Novartis, Pfizer, Sun, UCB.